Dr. Marie Gabrielle Théry

My research project within the Radionuclide Development team is focused on optimizing Sc-44 production and purification processes to improve chemical purity and apparent molar activity, enhancing its suitability for preclinical and clinical applications. Our work also involves scaling up Sc-44 production, automating the radiolabeling synthesis and translating these procedures to radiopharmaceutical manufacturing.